Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS

Filed by STRATEGIC MARKETING INNOVATIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-17 06:26:11 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Apr 21, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
5864ddc0-013b-4519-9e36-167632c9184e
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

HCR · Health Issues

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

DIS · Disaster Planning/Emergencies

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.